サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1303815

ボツリヌス毒素の世界市場：タイプ別、用途別 - 2023年～2030年の予測

Botulinum Toxins Market by Type (AbobotulinumtoxinA, IncobotulinumtoxinA, OnabotulinumtoxinA), Application (Aesthetic, Therapeutic) - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 197 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ボツリヌス毒素の世界市場：タイプ別、用途別 - 2023年～2030年の予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 197 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のボツリヌス毒素の市場規模はCAGR15.46％で大きく成長し、2023年に49億3,408万米ドルとなり、2030年までに135億1,674万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のボツリヌス毒素市場を評価するために不可欠です。事業戦略や製品満足度などの主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.ボツリヌス毒素の世界市場規模および予測は？

2.予測期間中、ボツリヌス毒素の世界市場を形成するCOVID-19の阻害要因と影響は？

3.ボツリヌス毒素の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.ボツリヌス毒素の世界市場における競争戦略は？

5.ボツリヌス毒素の世界市場における技術動向と規制の枠組みは？

6.ボツリヌス毒素の世界市場における主要ベンダーの市場シェアは？

7.ボツリヌス毒素の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 非侵襲的な美容処置の数が増加
      • 自分の外見を意識する人が増加
      • 高齢化人口の増加により、肌を若く見せるための施術に対する需要が高まっている
    • 抑制要因
      • 比較的高額な手続き費用
    • 機会
      • 製品承認数の増加と新製品の発売
      • ボツリヌス毒素の治療的および美容的応用に対する意識の高まり
    • 課題
      • この手順で起こり得る副作用
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 ボツリヌス毒素市場：タイプ別

  • アボボツリヌス毒素A
  • インコボツリヌス毒素A
  • オナボツリヌス毒素A
  • リマボツリヌス毒素B

第7章 ボツリヌス毒素市場：用途別

  • 美容用
  • 治療用
    • 眼瞼けいれん
    • 下肢の痙縮を伴う尖足部
    • 片側顔面けいれん
    • 過活動膀胱と神経因性膀胱
    • 原発性腋窩多汗症
    • けいれん性発声障害
    • けいれん性斜頸
    • 斜視
    • 上肢および下肢の痙縮

第8章 南北アメリカのボツリヌス毒素市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域のボツリヌス毒素市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカのボツリヌス毒素市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第12章 掲載企業一覧

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. BOTULINUM TOXINS MARKET RESEARCH PROCESS
  • FIGURE 2. BOTULINUM TOXINS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. BOTULINUM TOXINS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. BOTULINUM TOXINS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. BOTULINUM TOXINS MARKET DYNAMICS
  • FIGURE 8. BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. BOTULINUM TOXINS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. BOTULINUM TOXINS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. BOTULINUM TOXINS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. BOTULINUM TOXINS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. BOTULINUM TOXINS MARKET SIZE, BY ABOBOTULINUMTOXINA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. BOTULINUM TOXINS MARKET SIZE, BY INCOBOTULINUMTOXINA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BOTULINUM TOXINS MARKET SIZE, BY ONABOTULINUMTOXINA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. BOTULINUM TOXINS MARKET SIZE, BY RIMABOTULINUMTOXINB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 10. BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 12. BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. BOTULINUM TOXINS MARKET SIZE, BY BLEPHAROSPASM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. BOTULINUM TOXINS MARKET SIZE, BY EQUINUS FOOT ASSOCIATED WITH LOWER LIMB SPASTICITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. BOTULINUM TOXINS MARKET SIZE, BY HEMIFACIAL SPASM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. BOTULINUM TOXINS MARKET SIZE, BY OVERACTIVE BLADDER & NEUROGENIC BLADDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. BOTULINUM TOXINS MARKET SIZE, BY PRIMARY AXILLARY HYPERHIDROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. BOTULINUM TOXINS MARKET SIZE, BY SPASMODIC DYSPHONIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. BOTULINUM TOXINS MARKET SIZE, BY SPASMODIC TORTICOLLIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. BOTULINUM TOXINS MARKET SIZE, BY STRABISMUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. BOTULINUM TOXINS MARKET SIZE, BY UPPER & LOWER LIMB SPASTICITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 149. BOTULINUM TOXINS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 150. BOTULINUM TOXINS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 151. BOTULINUM TOXINS MARKET LICENSE & PRICING
目次
Product Code: MRR-4330CC794BDB

The Global Botulinum Toxins Market is forecasted to grow significantly, with a projected USD 4,934.08 million in 2023 at a CAGR of 15.46% and expected to reach a staggering USD 13,516.74 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Botulinum Toxins Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Botulinum Toxins Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across AbobotulinumtoxinA, IncobotulinumtoxinA, OnabotulinumtoxinA, and RimabotulinumtoxinB. The OnabotulinumtoxinA is projected to witness significant market share during forecast period.

Based on Application, market is studied across Aesthetic and Therapeutic. The Therapeutic is further studied across Blepharospasm, Equinus Foot Associated With Lower Limb Spasticity, Hemifacial Spasm, Overactive Bladder & Neurogenic Bladder, Primary Axillary Hyperhidrosis, Spasmodic Dysphonia, Spasmodic Torticollis, Strabismus, and Upper & Lower Limb Spasticity. The Aesthetic is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Botulinum Toxins Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Botulinum Toxins Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Botulinum Toxins Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Botulinum Toxins Market?

4. What is the competitive strategic window for opportunities in the Global Botulinum Toxins Market?

5. What are the technology trends and regulatory frameworks in the Global Botulinum Toxins Market?

6. What is the market share of the leading vendors in the Global Botulinum Toxins Market?

7. What modes and strategic moves are considered suitable for entering the Global Botulinum Toxins Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Botulinum Toxins Market, by Type, 2022 vs 2030
  • 4.3. Botulinum Toxins Market, by Application, 2022 vs 2030
  • 4.4. Botulinum Toxins Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of non-invasive cosmetic procedures
      • 5.1.1.2. Increasing individuals highly conscious of their appearance
      • 5.1.1.3. Rising aging population demand for procedures to make their skin look young
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively high cost of the procedure
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing number of product approvals and launch of novel products
      • 5.1.3.2. Surging awareness of therapeutic and cosmetic application of botulinum toxin
    • 5.1.4. Challenges
      • 5.1.4.1. Probable side effects of the procedure
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Botulinum Toxins Market, by Type

  • 6.1. Introduction
  • 6.2. AbobotulinumtoxinA
  • 6.3. IncobotulinumtoxinA
  • 6.4. OnabotulinumtoxinA
  • 6.5. RimabotulinumtoxinB

7. Botulinum Toxins Market, by Application

  • 7.1. Introduction
  • 7.2. Aesthetic
  • 7.3. Therapeutic
    • 7.3.1. Blepharospasm
    • 7.3.2. Equinus Foot Associated With Lower Limb Spasticity
    • 7.3.3. Hemifacial Spasm
    • 7.3.4. Overactive Bladder & Neurogenic Bladder
    • 7.3.5. Primary Axillary Hyperhidrosis
    • 7.3.6. Spasmodic Dysphonia
    • 7.3.7. Spasmodic Torticollis
    • 7.3.8. Strabismus
    • 7.3.9. Upper & Lower Limb Spasticity

8. Americas Botulinum Toxins Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Botulinum Toxins Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Botulinum Toxins Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing